144 related articles for article (PubMed ID: 25685799)
1. Correlation of serum levels of endostatin with tumor stage in gastric cancer: a systematic review and meta-analysis.
Wang ZH; Zhu ZT; Xiao XY; Sun J
Biomed Res Int; 2015; 2015():623939. PubMed ID: 25685799
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment serum endostatin as a prognostic indicator in metastatic gastric carcinoma.
Woo IS; Kim KA; Jeon HM; Hong SH; Rho SY; Koh SJ; Lee MA; Byun JH; Kang JH; Hong YS; Lee KS; Cho CS; Choi MG; Chung IS
Int J Cancer; 2006 Dec; 119(12):2901-6. PubMed ID: 16998835
[TBL] [Abstract][Full Text] [Related]
3. Serum endostatin levels in gastric cancer patients: correlation with clinicopathological parameters.
Koç M; Göçmen E; Kiliç M; Ozbay M; Oktem M; Tez M
Hepatogastroenterology; 2006; 53(70):616-8. PubMed ID: 16995474
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-7 mRNA and protein expression in gastric carcinoma: a meta-analysis.
Long ZW; Wang JL; Wang YN
Tumour Biol; 2014 Nov; 35(11):11415-26. PubMed ID: 25123263
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of endostatin and EGF serum levels in patients with gastric cancer.
Masiak W; Szponar A; Chodorowska G; Dąbrowski A; Pedowski T; Wallner G
Pol Przegl Chir; 2011 Jan; 83(1):42-7. PubMed ID: 22166241
[TBL] [Abstract][Full Text] [Related]
6. Association between cadherin-17 expression and pathological characteristics of gastric cancer: a meta-analysis.
Long ZW; Zhou ML; Fu JW; Chu XQ; Wang YN
World J Gastroenterol; 2015 Mar; 21(12):3694-705. PubMed ID: 25834338
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic value of circulating tumor DNA in gastric cancer: a meta-analysis.
Gao Y; Zhang K; Xi H; Cai A; Wu X; Cui J; Li J; Qiao Z; Wei B; Chen L
Oncotarget; 2017 Jan; 8(4):6330-6340. PubMed ID: 28009985
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of pretreatment serum level of endostatin to posttreatment distant metastasis in patients with advanced nasopharyngeal carcinoma].
Zhao ZJ; Mo HY; Zhang CQ; Qi B; Li J; Hong MH; Mai HQ
Ai Zheng; 2007 Nov; 26(11):1243-7. PubMed ID: 17991326
[TBL] [Abstract][Full Text] [Related]
9. Correlations between serum levels of vascular endothelial growth factor and endostatin with clinical pathological characteristics of patients with gastrointestinal cancers.
Li M; Liu F; Sun P; Gao Y; Chen H; Liu H; Wang M; Chen J; Zhao Y
Hepatogastroenterology; 2012 Sep; 59(118):1865-8. PubMed ID: 22819906
[TBL] [Abstract][Full Text] [Related]
10. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
[TBL] [Abstract][Full Text] [Related]
11. Serum endostatin levels are elevated in colorectal cancer and correlate with invasion and systemic inflammatory markers.
Kantola T; Väyrynen JP; Klintrup K; Mäkelä J; Karppinen SM; Pihlajaniemi T; Autio-Harmainen H; Karttunen TJ; Mäkinen MJ; Tuomisto A
Br J Cancer; 2014 Oct; 111(8):1605-13. PubMed ID: 25137019
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
[TBL] [Abstract][Full Text] [Related]
13. Serum endostatin levels in patients with lung carcinoma.
Swidzińska E; Ossolińska M; Naumnik W; Trojan S; Chyczewska E
Rocz Akad Med Bialymst; 2005; 50():197-200. PubMed ID: 16358965
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of serum levels of endostatin in patients with clear cell renal cell carcinoma].
Guan KP; Xiao ZD; Wang D; Shi HZ; Guan YY; Lu L; Han SJ; Li CL
Zhonghua Wai Ke Za Zhi; 2009 May; 47(10):737-9. PubMed ID: 19615205
[TBL] [Abstract][Full Text] [Related]
15. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y
BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164
[TBL] [Abstract][Full Text] [Related]
16. Endostatin gene variation and protein levels in breast cancer susceptibility and severity.
Balasubramanian SP; Cross SS; Globe J; Cox A; Brown NJ; Reed MW
BMC Cancer; 2007 Jun; 7():107. PubMed ID: 17587451
[TBL] [Abstract][Full Text] [Related]
17. Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer.
Szarvas T; László V; Vom Dorp F; Reis H; Szendröi A; Romics I; Tilki D; Rübben H; Ergün S
Int J Cancer; 2012 Jun; 130(12):2922-9. PubMed ID: 21815140
[TBL] [Abstract][Full Text] [Related]
18. Clinical Significance of Serum p53 Antibody in the Early Detection and Poor Prognosis of Gastric Cancer.
Kunizaki M; Fukuda A; Wakata K; Tominaga T; Nonaka T; Miyazaki T; Matsumoto K; Sumida Y; Hidaka S; Yasutake T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
Anticancer Res; 2017 Apr; 37(4):1979-1984. PubMed ID: 28373470
[TBL] [Abstract][Full Text] [Related]
19. Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer.
Lim JB; Chung HW
Cytokine; 2015 May; 73(1):16-22. PubMed ID: 25689618
[TBL] [Abstract][Full Text] [Related]
20. [The value of serum endostatin level in early diagnosis of lung cancer].
Xu AH; Yin YW; Chen FH
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(27):1916-8. PubMed ID: 17064531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
